SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-186171
Filing Date
2022-06-30
Accepted
2022-06-30 16:10:35
Documents
6
Effectiveness Date
2022-06-30

Document Format Files

Seq Description Document Type Size
1 S-8 d322191ds8.htm S-8 61903
2 EX-5.1 d322191dex51.htm EX-5.1 8285
3 EX-23.1 d322191dex231.htm EX-23.1 9877
4 EX-FILING FEES d322191dexfilingfees.htm EX-FILING FEES 37227
5 GRAPHIC g322191g22a05.jpg GRAPHIC 2917
6 GRAPHIC g322191kpmg.jpg GRAPHIC 9398
  Complete submission text file 0001193125-22-186171.txt   135679
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265927 | Film No.: 221058143
SIC: 2836 Biological Products, (No Diagnostic Substances)